Clinical Observation of Bupi Qingfei Decoction in Treatment of<italic style="font-style: italic"> </italic>Bronchiectasis Colonized by <italic style="font-style: italic">Pseudomonas aeruginosa</italic>

Sha-sha YUAN; Ning WANG; Qing MIAO

doi:10.13422/j.cnki.syfjx.20212493

您当前的位置：

首页 >

文章列表页 >

Clinical Observation of Bupi Qingfei Decoction in Treatment of Bronchiectasis Colonized by Pseudomonas aeruginosa

更新时间：2021-11-12

- Clinical Observation of Bupi Qingfei Decoction in Treatment of Bronchiectasis Colonized by Pseudomonas aeruginosa
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 24, Pages: 118-124(2021)
- 作者机构：
  
  1.中国中医科学院，北京 100700
  2.中国中医科学院西苑医院，北京 100091
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20212493
  CLC： R22;R242;R2-031;R562.2+2
- Received：05 April 2021，
  
  Published Online：28 October 2021，
  
  Published：20 December 2021
- 稿件说明：
移动端阅览
袁沙沙,王宁,苗青.补脾清肺汤治疗铜绿假单胞菌定植支气管扩张症患者的临床疗效[J].中国实验方剂学杂志,2021,27(24):118-124.

YUAN Sha-sha,WANG Ning,MIAO Qing.Clinical Observation of Bupi Qingfei Decoction in Treatment ofBronchiectasis Colonized by Pseudomonas aeruginosa[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):118-124.
袁沙沙,王宁,苗青.补脾清肺汤治疗铜绿假单胞菌定植支气管扩张症患者的临床疗效[J].中国实验方剂学杂志,2021,27(24):118-124. DOI： 10.13422/j.cnki.syfjx.20212493.

YUAN Sha-sha,WANG Ning,MIAO Qing.Clinical Observation of Bupi Qingfei Decoction in Treatment ofBronchiectasis Colonized by Pseudomonas aeruginosa[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(24):118-124. DOI： 10.13422/j.cnki.syfjx.20212493.

摘要

目的

评价补脾清肺汤治疗铜绿假单胞菌（PA）定植支气管扩张症（肺脾气虚、痰热蕴肺证）患者的临床疗效。

方法

将72例PA定植支气管扩张症（肺脾气虚、痰热蕴肺证）患者随机分为观察组和对照组各36例（观察组失访2例，退出3例，完成31例；对照组失访3例，退出4例，完成29例）。观察组口服补脾清肺汤颗粒剂，隔日1剂，早晚2次冲服；联合服用阿奇霉素片模拟片，0.5 g，隔日1次。对照组口服阿奇霉素片0.5 g，隔日1次；联合口服补脾清肺汤颗粒剂模拟剂，隔日1剂，早晚2次冲服。两组患者均进行健康教育及体位排痰。疗程24周，随访24周。评价治疗后两组患者急性加重次数、生活质量（圣·乔治呼吸问卷）评分、中医证候积分、肺功能［第1秒用力呼气容积占预计值的百分比（FEV

%pred），第1秒用力呼气容积与用力肺活量的比值（FEV

/FVC）］及血清免疫球蛋白（Ig）A，IgE，IgG，IgM水平变化。

结果

观察组治疗24周及随访24周后急性加重次数低于对照组患者（

0.05）。与本组治疗前比较，观察组治疗24周后生活质量（圣·乔治呼吸问卷）总分及症状评分明显下降（

0.05）；对照组治疗12周及24周后生活质量改善差异无统计学意义。观察组治疗12周后中医证候疗效有效率为64.52%（20/31），对照组为31.03%（9/29），观察组明显高于对照组（

=6.726，

0.05），治疗24周后观察组有效率为83.87%（26/31），对照组为68.97%（20/29），观察组高于对照组，但差异无统计学意义。观察组治疗12周及24周后咳嗽、咳痰、乏力、纳呆、自汗、腹胀、便溏等症状得分改善明显优于对照组（

0.05）。观察组及对照组在肺功能及血清免疫球蛋白方面差异无统计学意义。

结论

补脾清肺汤治疗PA定植支气管扩张症（肺脾气虚、痰热蕴肺证）患者，可减少患者的急性加重次数，改善症状及生活质量。

Abstract

Objective

To evaluate the clinical efficacy of Bupi Qingfei decoction in the treatment of bronchiectasis colonized by

Pseudomonas aeruginosa

（PA）（lung-spleen Qi deficiency syndrome and phlegm heat accumulating in lung syndrome）.

Method

A total of 72 bronchiectasis patients colonized with PA （ lung-spleen Qi deficiency syndrome and phlegm heat accumulating in lung syndrome ） were randomly divided into the observation group （36 cases， two cases were lost to follow-up and three dropped out） and control group （36 cases， three cases were lost to follow-up and four dropped out）. There were 31 cases in the observation group and 29 cases in the control group completing the trial. Patients in the observation group were treated with Bupi Qingfei decoction orally，once in the morning and again in the evening， one bag every other day， and simulated azithromycin tablet at the dose of 0.5 g，once every other day， while those in the control group with azithromycin tablet at 0.5 g，once every other day， and simulated Bupi Qingfei decoction， once in the morning and again in the evening， one bag every other day. Patients in both groups received health education and postural expectoration. The treatment lasted for 24 weeks，followed by a 24-week follow-up. The frequency of acute exacerbation，quality of life （St. George's Respiratory Questionnaire） score，traditional Chinese medicine （TCM） syndrome score，lung function ［forced expiratory volume in one second percentage of predicted（FEV

%pred） and FEV

/forced vital capacity（FVC）］， and serum immunoglobulin （Ig）A，IgE，IgG，and IgM levels of the two groups were evaluated after treatment.

Result

The frequencies of acute exacerbation after 24 weeks of treatment and during the 24-week follow-up in the observation group were lower than those in the control group （

0.05）. The total quality of life （St. George's Respiratory Questionnaire） score and symptom scores in the observation group after 24 weeks of treatment were significantly decreased as compared with those before treatment （

0.05）. There was no significant improvement in the quality of life in the control group either after 24 weeks of treatment or during the 24-week follow-up. The effective rate against TCM syndrome in the observation group was 64.52%（20/31） after 12 weeks of treatment，which was obviously higher than 31.03%（9/29） in the control group （

=6.726，

0.05）. After 24 weeks of treatment，the effective rate in the observation group was 83.87%， slightly higher than 68.97% in the control group. After 12 and 24 weeks of treatment，the scores of cough，expectoration，fatigue，anorexia，spontaneous sweating，abdominal distension， and loose stool in the observation group were better than those in the control group （

0.05）. There were no significant changes in lung function and serum immunoglobulin classes in the two groups.

Conclusion

Bupi Qingfei decoction is effective in reducing the frequency of acute exacerbation， alleviating the symptoms， and improving the quality of life of bronchiectasis patients colonized by PA （lung-spleen Qi deficiency syndrome and phlegm heat accumulating in lung syndrome）.

关键词

Keywords

references

蔡柏蔷，何权瀛，高占成，等 . 成人支气管扩张症诊治专家共识（2012版）［J］. 中华危重症医学杂志：电子）， 2012 ， 5 （ 5 ）： 315 - 328 .

TUNNEY M M ， EINARSSON G G ， WEI L ， et al . Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation ［J］. Am J Respir Crit Care Med ， 2013 ， 187 （ 10 ）： 1118 - 1126 .

CHALMERS J D ， SMITH M P ， MCHUGH B J ， et al . Shortand longterm antibiotic treatment reduces airway and systemic inflammation in noncystic fibrosis bronchiectasis ［J］. Am J Respir Crit Care Med ， 2012 ， 186 （ 7 ）： 657 - 665 .

DAVIES G ， WELLS A U ， DOFFMAN S ， et al . The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis ［J］. Eur Respir J ， 2006 ， 28 （ 5 ）： 974 - 979 .

CHAWLA K ， VISHWANATH S ， MANU M K ， et al . Influence of pseudomonas aeruginosa on exacerbation in patients with bronchiectasis ［J］. J Glob Infect Dis ， 2015 ， 7 （ 1 ）： 18 - 22 .

WILSON C B ， JONES P W ， O′LEARY C J ， et al . Effect of sputum bacteriology on the quality of life of patients with bronchiectasis ［J］. Eur Respir J ， 1997 ， 10 （ 8 ）： 1754 - 1760 .

LOEBINGER M R ， WELLS A U ， HANSELL D M ， et al . Mortality in bronchiectasis：a longterm study assessing the factors influencing survival ［J］. Eur Respir J ， 2009 ， 34 （ 4 ）： 843 - 849 .

WANG R C ， DING S Z ， LEI C ， The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis：a prospective cohort study ［J］. Ann Med ， 2021 ， 53 （ 1 ）： 459 - 469 .

CHALMERS J D ， BOERSMA W ， LONERGAN M ， et al . Long-term macrolide antibiotics for the treatment of bronchiectasis in adults：an individual participant data meta-analysis ［J］. Lancet Respir Med ， 2019 ， 7 （ 10 ）： 845 - 854 .

CONROY W ， LATA J ， NOELETAL K ， et al . Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis （EMBRACE）：a randomised，double-blind，placebo-controlled trial ［J］. Lancet ， 2012 ， 380 （ 9842 ）： 660 - 667 .

SERISIER D J ， MARTIN M L ， MCGUCKIN M A ， et al . Effect of long-term，low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis：the BLESS randomized controlled trial ［J］. JAMA ， 2013 ， 309 （ 12 ）： 1260 - 1267

刘积锋，钟小宁，何志义，等 . 小剂量罗红霉素对支气管扩张症稳定期治疗的影响［J］. 中华结核和呼吸杂志， 2012 ， 35 （ 11 ）： 824 - 827 .

张怡，范莉超，徐金富 . 长期低剂量大环内酯类药物在支气管扩张症中的应用及安全性［J］. 实用药物与临床， 2018 ， 21 （ 11 ）： 1301 - 1304 .

徐波，张静，任培中，等 . 90例支气管扩张症稳定期患者中医证候与体质类型调查研究［J］. 山东中医杂志， 2017 ， 36 （ 12 ）： 1026 - 1029，1062 .

宋雪萍 . 补脾清肺汤治疗支气管扩张症（脾虚肺热证）的临床观察［D］. 北京：北京中医药大学， 2015 ： 30 - 31 .

HILL A T ， HAWORTH C S ， ALIBERTI S ， et al . Pulmonary exacerbation in adults with bronchiectasis：a consensus definition for clinical research ［J］. Eur Respir J ， 2017 ， 49 （ 6 ）： 1700051 .

中华中医药学会 . 中医内科常见病诊疗指南中医病证部分［M］. 北京：中国中医药出版社， 2008 ： 17 - 18 .

郑筱萸 . 中药新药临床研究指导原则（试行）［M］. 北京：中国医药科技出版社， 2002 ：14， 15 ， 22 - 23 ， 65 .

JONES P W ， QUIRK F H ， BAVEYSTOCK C M . The St Georg's respiratory questionnaire ［J］. Respir Med ， 1991 ， 85 （ Suppl B ）： 25 - 31 .

RYALL B ， DAVIES J C ， WILSON R ， et al . Pseudomonas aeruginosa ，cyanide accumulation and lung function in CF and nonCF bronchiectasis patients ［J］. Eur Respir J ， 2008 ， 32 （ 3 ）： 740 - 747 .

LUO R G ， MIAO X Y ， LUO L L ， et al . Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients ［J］. Clin Microbiol Infect ， 2019 ， 25 （ 5 ）： 601 - 606 .

ALTENBURG J ， DE GRAAFF C S ， STIENSTRA Y ， et al . Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis：the BAT randomized controlled trial ［J］. JAMA ， 2013 ， 309 （ 12 ）： 1251 - 1259 .

付跃峰，孔令博，姜尚上，等 . 刘清泉教授治疗耐药菌感染学术思想探讨［J］. 中国中医急症， 2020 ， 29 （ 1 ）： 136 - 138+142 .

张旭宏，李英洲，王艳秋，等 . 参芪扶正注射液对结肠癌术后行化疗患者免疫功能的影响［J］. 中国实用医药， 2009 ， 4 （ 13 ）： 129 - 130 .

王玉婷，徐红日，赵世同，等 . 扶正解毒化瘀方对多重耐药铜绿假单胞菌MexAB-OprM外排泵表达影响的研究［J］. 世界中医药， 2019 ， 14 （ 4 ）： 859 - 863 .

李振，李萍，唐健萍 . 22种中草药体外抗菌作用的研究［J］. 实验室科学， 2013 ， 16 （ 5 ）： 9 - 12 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Modified Qingjin Huatan Tang on Bronchiectasis with Syndrome of Phlegm-heat Accumulating Lung at Acute Exacerbation

Correlation Between Quality of Life and Traditional Chinese Medicine Syndromes in Patients with Myasthenia Gravis

Clinical Effect of Qingbu Weijing Decoction on Patients Suffering from Stable Bronchiectasis Complicated with Airway Mucus Hypersecretion

Advantages of Chinese Medicine in Improving Airway Mucus Hypersecretion in Stable Bronchiectasis Patients

Effect of Modified Qilang Prescription on Drug-dependent Constipation of Qi-Yin Deficiency Type

Related Author

Guan-lin DI

Zhen-gang ZHU

Yan-long ZHENG

ZHANG Yibin

LU Qi

WANG Baitong

QI Yixun

XU Hanying

Related Institution

First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Changchun University of Chinese Medicine

The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine

The Affiliated Hospital of Changchun University of Chinese Medicine

Beijing University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Clinical Observation of Bupi Qingfei Decoction in Treatment of Bronchiectasis Colonized by Pseudomonas aeruginosa

DOI：10.13422/j.cnki.syfjx.20212493

摘要

Abstract

关键词

Keywords

references